These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 13908449)
1. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures. HOLLISTER LE; HARTMAN AM Compr Psychiatry; 1962 Aug; 3():235-42. PubMed ID: 13908449 [No Abstract] [Full Text] [Related]
2. Comparison of psilocin with psilocybin, mescaline and LSD-25. WOLBACH AB; MINER EJ; ISBELL H Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905 [No Abstract] [Full Text] [Related]
3. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION. HARTMAN AM; HOLLISTER LE Psychopharmacologia; 1963 Aug; 4():441-51. PubMed ID: 14048565 [No Abstract] [Full Text] [Related]
4. Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions. WOLBACH AB; ISBELL H; MINER EJ Psychopharmacologia; 1962 Mar; 3():1-14. PubMed ID: 14007904 [No Abstract] [Full Text] [Related]
5. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS. HOLLISTER LE; SJOBERG BM Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873 [No Abstract] [Full Text] [Related]
6. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080 [TBL] [Abstract][Full Text] [Related]
9. Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements. Hebbard FW; Fischer R Psychopharmacologia; 1966; 9(2):146-56. PubMed ID: 5983913 [No Abstract] [Full Text] [Related]
10. [APROPOS OF OPTIC DISORDERS IN AUTOEXPERIMENTS WITH HALLUCINOGENS]. GROF S Cesk Psychiatr; 1964 Jun; 60():173-82. PubMed ID: 14177526 [No Abstract] [Full Text] [Related]
11. [Psycho-dysleptics]. Polvan O Turk Tip Cemiy Mecm; 1966 Nov; 32(11):661-70. PubMed ID: 5979072 [No Abstract] [Full Text] [Related]
12. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats]. MAFFII G Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753 [No Abstract] [Full Text] [Related]
13. [Various psychodysleptic substances]. Bernik V Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580 [No Abstract] [Full Text] [Related]
14. The effects of psychotomimetic drugs on primary suggestibility. Sjoberg BM; Hollister LE Psychopharmacologia; 1965 Nov; 8(4):251-62. PubMed ID: 5885648 [No Abstract] [Full Text] [Related]
16. SOURCES OF VARIATION IN REPEATED MEASUREMENT OF PLASMA FREE FATTY ACIDS IN RESTED FASTING SUBJECTS. Hollister LE; Overall JE Am J Clin Nutr; 1964 Sep; 15():149-57. PubMed ID: 14212749 [No Abstract] [Full Text] [Related]
17. Effects of excitatory and tranquilizing drugs on visual perception. Hill RM; Fischer R; Warshay D Am J Optom Arch Am Acad Optom; 1968 Jul; 45(7):454-7. PubMed ID: 5243948 [No Abstract] [Full Text] [Related]
18. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties. Schechter MD; Rosecrans JA Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050 [No Abstract] [Full Text] [Related]
19. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug. Snyder SH; Faillace L; Hollister L Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952 [TBL] [Abstract][Full Text] [Related]
20. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS. CHARALAMPOUS KD; KINROSS-WRIGHT J Tex State J Med; 1963 Sep; 59():848-52. PubMed ID: 14054727 [No Abstract] [Full Text] [Related] [Next] [New Search]